Moreover, breast cancer initiating cells display down-regulation of ERα and clonal expansion of these CD44+/CD24low/−/ERαlow/− cancer cells may be responsible for tumor recurrence and development of distant metastases of initially ERα+ breast carcinomas [12], [13]. This evidence concerns the gene ESR1 and neoplasm.